Biocon stock ticks up as Yesafili Biosimilar clinical data gets published in peer-reviewed journals
Biocon stock ticks up as Yesafili Biosimilar clinical data gets published in peer-reviewed journals — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.